Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis


Current price
5.1 USD -0.05 USD (-0.97%)
Last closed 5.22 USD
Sector Healthcare
Industry Medical Distribution
Exchange NASDAQ
Capitalization 188 329 744 USD
Yield for 12 month -53.68 %
21.11.2021 - 28.11.2021

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Lyon, France. Address: Parc dActivites la Poudrette-Lamartine, Lyon, France, 69120


WallStreet Target Price

11.66 USD

P/E ratio

Dividend Yield

3.6 %

Current Year

+59 995 645 USD

Last Year

+47 973 436 USD

Current Quarter

+12 777 748 USD

Last Quarter

+15 545 153 USD

Current Year

+26 338 251 USD

Last Year

+20 056 611 USD

Current Quarter

+4 532 143 USD

Last Quarter

+6 157 531 USD

Key Figures EDAP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 532 250 USD
Operating Margin TTM -47.29 %
PE Ratio
Return On Assets TTM -11.3 %
PEG Ratio 90.47
Return On Equity TTM -31.66 %
Wall Street Target Price 11.66 USD
Revenue TTM 56 529 000 USD
Book Value 1.62 USD
Revenue Per Share TTM 1.53 USD
Dividend Share
Quarterly Revenue Growth YOY -4.1 %
Dividend Yield 3.6 %
Gross Profit TTM 24 194 000 USD
Earnings Share -0.65 USD
Diluted Eps TTM -0.65 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -62.2 %
Profit Margin -37.62 %

Dividend Analytics EDAP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EDAP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 3.6 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EDAP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 38.0228
Enterprise Value Revenue 2.5296
Price Sales TTM 3.3316
Enterprise Value EBITDA -9.1825
Price Book MRQ 2.8891

Financials EDAP

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators EDAP

For 52 weeks

3.6 USD 12.65 USD
50 Day MA 6.14 USD
Shares Short Prior Month 113 125
200 Day MA 8.82 USD
Short Ratio 0.51
Shares Short 120 969
Short Percent 0.33 %